Trafalgar International, Inc. SEC filings TRFA
Trafalgar International, Inc. has 144 filings in SEC EDGAR's recent list, going back to Jun 20, 2017. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (bylaw or fiscal year change, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SC 14F1 | Filing | Jul 31, 2026 | — |
| SC 14F1 | Filing | Jul 6, 2026 | — |
| UPLOAD | Letter from the SEC | May 22, 2025 | — |
| CORRESP | Letter to the SEC | May 5, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 25, 2025 | — |
| PRER14C | Filing | Feb 26, 2024 | — |
| NT 10-K | Filing | Apr 3, 2023 | Dec 31, 2022 |
| NT 10-K | Filing | Apr 1, 2022 | Dec 31, 2021 |
| NT 10-Q | Filing | Aug 17, 2021 | Jun 30, 2021 |
| EFFECT | Filing | Jun 28, 2021 | — |
| CORRESP | Letter to the SEC | Jun 24, 2021 | — |
| CORRESP | Letter to the SEC | Jun 14, 2021 | — |
| UPLOAD | Letter from the SEC | May 24, 2021 | — |
| NT 10-Q | Filing | Nov 16, 2020 | Sep 30, 2020 |
| NT 10-Q | Filing | Aug 13, 2020 | Jun 30, 2020 |
| EFFECT | Filing | Jul 17, 2020 | — |
| CORRESP | Letter to the SEC | Jul 15, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 14, 2020 | — |
| NT 10-Q | Filing | May 15, 2020 | Mar 31, 2020 |
| NT 10-K | Filing | Mar 30, 2020 | Dec 31, 2019 |
| EFFECT | Filing | Feb 12, 2020 | — |
| CORRESP | Letter to the SEC | Feb 10, 2020 | — |
| CORRESP | Letter to the SEC | Feb 10, 2020 | — |
| UPLOAD | Letter from the SEC | Jan 27, 2020 | — |
| NT 10-Q | Filing | Nov 13, 2019 | Sep 30, 2019 |
| NT 10-Q | Filing | Aug 13, 2019 | Jun 30, 2019 |
| UPLOAD | Letter from the SEC | Aug 7, 2019 | — |
| UPLOAD | Letter from the SEC | Jul 12, 2019 | — |
| NT 10-Q | Filing | May 15, 2019 | Mar 31, 2019 |
| NT 10-K | Filing | Mar 28, 2019 | Dec 31, 2018 |
| 8-A12G | Filing | Feb 14, 2019 | — |
| NT 10-Q | Filing | Nov 14, 2018 | Sep 30, 2018 |
| NT 10-Q | Filing | Aug 14, 2018 | Jun 30, 2018 |
| EFFECT | Filing | Jul 9, 2018 | — |
| NT 10-Q | Filing | May 14, 2018 | Mar 31, 2018 |
| NT 10-K | Filing | Apr 2, 2018 | Dec 31, 2017 |
| NT 10-Q | Filing | Nov 13, 2017 | Sep 30, 2017 |
| EFFECT | Filing | Aug 31, 2017 | — |
| CORRESP | Letter to the SEC | Aug 29, 2017 | — |
| CORRESP | Letter to the SEC | Aug 25, 2017 | — |
| UPLOAD | Letter from the SEC | Aug 24, 2017 | — |
| CORRESP | Letter to the SEC | Aug 8, 2017 | — |
| UPLOAD | Letter from the SEC | Aug 1, 2017 | — |
| CORRESP | Letter to the SEC | Jul 20, 2017 | — |
| UPLOAD | Letter from the SEC | Jul 14, 2017 | — |
Showing 45 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TRFA (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- FL
- Headquarters
- Miami, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1695473
- Former names
- Greater Cannabis Company, Inc. (until Jul 31, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.